PARP1 and cancer: Disturbances in the system of PAR-mediated formation of biomolecule condensates have been implicated in the onset and progression of various pathological states, such as cancer, viral infections, and neurodegeneration; thus, control over the formation and dynamics of such condensates by means of a combination of PARP1 inhibitors may be key to the treatment of some human diseases [183,223].